Targeting α- and β-adrenergic receptors differentially shifts Th1, Th2, and inflammatory cytokine profiles in immune organs to attenuate adjuvant arthritis

Frontiers in Immunology

Volumn 5, Issue AUG, 2014, Pages

  Lubahn, Cheri L ^a   Lorton, Dianne ^a   Schaller, Jill A ^a   Sweeney, Sarah J ^a   Bellinger, Denise L ^b  

^a KENT STATE UNIVERSITY   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokine balance; Lymph nodes; Macrophage; Peripheral blood mononuclear cells; Rheumatoid arthritis; Spleen; Sympathetic nervous system; T cell

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; PHENTOLAMINE; TERBUTALINE; TUMOR NECROSIS FACTOR;

ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL PROLIFERATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; MALE; MESENTERY LYMPH NODE; NONHUMAN; OSTEOLYSIS; RAT; RHEUMATOID ARTHRITIS; SPLEEN WEIGHT; TH1 CELL; TH2 CELL;

EID: 84987811480     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00346     Document Type: Article

References (95)

1. Ramos-Remus C, Duran-Barragan S, Castillo-Ortiz JD. Beyond the joints: neurological involvement in rheumatoid arthritis. Clin Rheumatol (2012) 31:1-12. doi: 10.1007/s10067-011-1841-z
2. Koopman FA, Stoof SP, Straub RH, Van Maanen MA, Vervoordeldonk MJ, Tak PP. Restoring the balance of the autonomic nervous system as an innovative approach to the treatment of rheumatoid arthritis. Mol Med (2011) 17:937-48. doi:10.2119/molmed.2011.00065
3. del Rey A, Wolff C, Wildmann J, Randolf A, Hahnel A, Besedovsky HO, et al. Disrupted brain-immune system-joint communication during experimental arthritis. Arthritis Rheum (2008) 58:3090-9. doi:10.1002/art.23869
4. Straub RH, Härle P. Sympathetic neurotransmitters in joint inflammation. Rheum Dis Clin North Am (2005) 31:43-59,viii. doi:10.1016/j.rdc.2004.09.003
5. Pablos JL, Cañete JD. Immunopathology of rheumatoid arthritis. Curr Top Med Chem (2013) 13:705-11. doi:10.2174/1568026611313060003
6. Rodríguez-Fernández JL. Antigen presentation by dendritic cells in rheumatoid arthritis. Curr Top Med Chem (2013) 13:712-9. doi:10.2174/1568026611313060004
7. Yadav RK, Gupta R, Deepak KK. A pilot study on short term heart rate variability & its correlation with disease activity in Indian patients with rheumatoid arthritis. Indian J Med Res (2012) 136:593-8.
8. Härle P, Straub RH, Wiest R, Mayer A, Schölmerich J, Atzeni F, et al. Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems. Ann Rheum Dis (2006) 65:51-6. doi:10.1136/ard.2005.038059
9. Levine JD, Coderre TJ, Helms C, Basbaum AI. Beta 2-adrenergic mechanisms in experimental arthritis. Proc Natl Acad Sci U S A (1988) 85:4553-6. doi:10.1073/pnas.85.12.4553
10. Malfait AM, Malik AS, Marinova-Mutafchieva L, Butler DM, Maini RN, Feldmann M. The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action. J Immunol (1999) 162:6278-83.
11. Lorton D, Lubahn C, Bellinger DL. Potential use of drugs that target neural-immune pathways in the treatment of rheumatoid arthritis and other autoimmune diseases. Curr Drug Targets Inflamm Allergy (2003) 2:1-30. doi:10.2174/1568010033344499
12. Lubahn CL, Schaller JA, Bellinger DL, Sweeney S, Lorton D. The importance of timing of adrenergic drug delivery in relation to the induction and onset of adjuvant-induced arthritis. Brain Behav Immun (2004) 18:563-71. doi:10.1016/j.bbi.2004.02.004
13. Härle P, Möbius D, Carr DJ, Schölmerich J, Straub RH. An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis. Arthritis Rheum (2005) 52:1305-13. doi:10.1002/art.20987
14. Lorton D, Lubahn C, Lindquist CA, Schaller J, Washington C, Bellinger DL. Changes in the density and distribution of sympathetic nerves in spleens from Lewis rats with adjuvant-induced arthritis suggest that an injury and sprouting response occurs. J Comp Neurol (2005) 489:260-73. doi:10.1002/cne.20640
15. Lorton D, Lubahn C, Sweeney S, Major A, Lindquist CA, Schaller J, et al. Differences in the injury/sprouting response of splenic noradrenergic nerves in Lewis rats with adjuvant-induced arthritis compared with rats treated with 6-hydroxydopamine. Brain Behav Immun (2009) 23:276-85. doi:10.1016/j.bbi.2008.10.004
16. Lorton D, Lubahn C, Klein N, Schaller J, Bellinger DL. Dual role for noradrenergic innervation of lymphoid tissue and arthritic joints in adjuvant-induced arthritis. Brain Behav Immun (1999) 13:315-34. doi:10.1006/brbi.1999.0564
17. Miller LE, Jüsten HP, Schölmerich J, Straub RH. The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J (2000) 14:2097-107. Erratum in: FASEB J (2003) 17(8):4A. FASEB J (2001) 15(13):2554. doi:10.1096/fj.99-1082com
18. Lorton D, Bellinger DL, Schaller JA, Shewmaker E, Osredkar T, Lubahn C. Altered sympathetic-to-immune cell signaling via β-adrenergic receptors in adjuvant arthritis. Clin Dev Immunol (2013) 2013:764395. doi:10.1155/2013/764395
19. Mishima K, Otani H, Tanabe T, Kawasaki H, Oshiro A, Saito N, et al. Molecular mechanisms for alpha2-adrenoceptor-mediated regulation of synoviocyte populations. Jpn J Pharmacol (2001) 85:214-26. doi:10.1254/jjp.85.214
20. Schaible HG, Straub RH. Function of the sympathetic supply in acute and chronic experimental joint inflammation. Auton Neurosci (2013) 182:55-64. doi:10.1016/j.autneu.2013
21. Bellinger DL, Lorton D. Autonomic regulation of cellular immune function. Auton Neurosci (2014) 182C:15-41. doi:10.1016/j.autneu.2014.01.006
22. Smol'nikova VV, Voznyuk AV, Potapnev MP. Cytokine-induced differentiation and proliferation of human T lymphocytes in vitro: effects of interleukin 2 and interleukin 6. Bull Exp Biol Med (2000) 129:567-70. doi:10.1007/BF02434879
23. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol (1986) 136:2348-57.
24. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell (1994) 76:241-51. doi:10.1016/0092-8674(94)90332-8
25. Ackerman NR, Rooks WH II, Shott L, Genant H, Maloney P, West E. Effects of naproxen on connective tissue changes in the adjuvant arthritic rat. Arthritis Rheum (1979) 22:1365-74. doi:10.1002/art.1780221208
26. Aitken SJ, Landao-Bassonga E, Ralston SH, Idris AI. Beta2-adrenoreceptor ligands regulate osteoclast differentiation in vitro by direct and indirect mechanisms. Arch Biochem Biophys (2009) 482:96-103. doi:10.1016/j.abb.2008.11.012
27. Huang HH, Brennan TC, Muir MM, Mason RS. Functional alpha1-and beta2-adrenergic receptors in human osteoblasts. J Cell Physiol (2009) 220:267-75. doi:10.1002/jcp.21761
28. Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature (2005) 434:514-20. doi:10.1038/nature03398
29. Suzuki A, Palmer G, Bonjour JP, Caverzasio J. Catecholamines stimulate the proliferation and alkaline phosphatase activity of MC3T3-E1 osteoblast-like cells. Bone (1998) 23:197-203. doi:10.1016/S8756-3282(98)00099-4
30. Lai LP, Mitchell J. Beta2-adrenergic receptors expressed on murine chondrocytes stimulate cellular growth and inhibit the expression of Indian hedgehog and collagen type X. J Cell Biochem (2008) 104:545-53. doi:10.1002/jcb.21646
31. Opolka A, Straub RH, Pasoldt A, Grifka J, Grässel S. Substance P and norepinephrine modulate murine chondrocyte proliferation and apoptosis. Arthritis Rheum (2012) 64:729-39. doi:10.1002/art.33449
32. Wythe SE, Nicolaidou V, Horwood NJ. Cells of the immune system orchestrate changes in bone cell function. Calcif Tissue Int (2014) 94:98-111. doi:10.1007/s00223-013-9764-0
33. Pérez E, García-Martínez O, Arroyo-Morales M, Reyes-Botella C, Ruiz C. Modulation of antigenic phenotype in cultured human osteoblast-like cells by FGFb, TGFbeta1, PDGF-BB, IL-2, IL-1beta, LPS and IFNgamma. Biosci Rep (2006) 26:281-9. doi:10.1007/s10540-006-9022-z
34. Tanaka Y, Nakayamada S, Okada Y. Osteoblasts and osteoclasts in bone remodeling and inflammation. Curr Drug Targets Inflamm Allergy (2005) 4:325-8. doi:10.2174/1568010054022015
35. Suleyman H, Halici Z, Cadirci E, Hacimuftuoglu A, Bilen H. Indirect role of beta2-adrenergic receptors the mechanism of anti-inflammatory action of NSAIDS. J Physiol Pharmacol (2008) 59:661-72.
36. Uzkeser H, Cadirci E, Halici Z, Odabasoglu F, Polat B, Yuksel TN, et al. Anti-inflammatory and antinociceptive effects of salbutamol on acute and chronic models of inflammation in rats: involvement of an antioxidant mechanism. Mediators Inflamm (2012) 2012:438912. doi:10.1155/2012/438912
37. 2 adrenergic receptor agonists in experimental acute lung injury. FASEB J (2012) 26:2137-44. doi:10.1096/fj.11-201640
38. Copik AJ, Ma C, Kosaka A, Sahdeo S, Trane A, Ho H, et al. Facilitatory interplay in alpha 1a and beta 2 adrenoceptor function reveals a non-Gq signaling mode: implications for diversification of intracellular signal transduction. Mol Pharmacol (2009) 75:713-28. doi:10.1124/mol.108.050765
39. Uberti MA, Hague C, Oller H, Minneman KP, Hall RA. Heterodimerization with beta2-adrenergic receptors promotes surface expression and functional activity of alpha1D-adrenergic receptors. J Pharmacol Exp Ther (2005) 313:16-23. doi:10.1124/jpet.104.079541
40. Vernon-Roberts B, Liyanage SP, Currey HL. Adjuvant arthritis in the rat. Distribution of fluorescent material after footpad injection of rhodamine-labelled tubercle bacilli. Ann Rheum Dis (1975) 35:389-97. doi:10.1136/ard.35.5.389
41. Cannon GW, Harper DS, Clayton F, Griffiths MM. Passive transfer of adjuvant-induced arthritis into irradiated DA recipient rats. Autoimmunity (1993) 15:267-74. doi:10.3109/08916939309115748
42. Cope AP, Liblau RS, Yang XD, Congia M, Laudanna C, Schreiber RD, et al. Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J Exp Med (1997) 185:1573-84. doi:10.1084/jem.185.9.1573
43. Kassiotis G, Kollias G. Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. J Exp Med (2001) 193:427-34. doi:10.1084/jem.193.4.427
44. Clark J, Vagenas P, Panesar M, Cope AP. What does tumour necrosis factor excess do to the immune system long term? Ann Rheum Dis (2005) 64(Suppl 4):iv70-6. doi:10.1136/ard.2005.042523
45. Cazaux CA, Sterin-Borda L, Gorelik G, Cremaschi GA. Down-regulation of beta-adrenergic receptors induced by mitogen activation of intracellular signaling events in lymphocytes. FEBS Lett (1995) 364:120-4. doi:10.1016/0014-5793(95)00366-H
46. Anakwe O, Zhou S, Benovic J, Aksoy M, Kelsen SG. Interleukins impair beta-adrenergic receptor adenylate cyclase (beta AR-AC) system function in human airway epithelial cells. Chest (1995) 107(3 Suppl):138S-9S. doi:10.1378/chest.107.3_Supplement.138S
47. Mak JC, Hisada T, Salmon M, Barnes PJ, Chung KF. Glucocorticoids reverse IL-1beta-induced impairment of beta-adrenoceptor-mediated relaxation and up-regulation of G-protein-coupled receptor kinases. Br J Pharmacol (2002) 135:987-96. doi:10.1038/sj.bjp.0704545
48. Grisanti LA, Perez DM, Porter JE. Modulation of immune cell function by a(1)-adrenergic receptor activation. Curr Top Membr (2011) 67:113-38. doi:10.1016/B978-0-12-384921-2.00006-9
49. Liao W, Lin JX, Leonard WJ. IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr Opin Immunol (2011) 23:598-604. doi:10.1016/j.coi.2011.08.003
50. Liao W, Schones DE, Oh J, Cui Y, Cui K, Roh TY, et al. Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor alpha-chain expression. Nat Immunol (2008) 9:1288-96. doi:10.1038/ni.1656
51. Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, Yao Z, et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity (2007) 26:371-81. doi:10.1016/j.immuni.2007.02.009
52. Ballesteros-Tato A, León B, Graf BA, Moquin A, Adams PS, Lund FE, et al. Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation. Immunity (2012) 36:847-56. doi:10.1016/j.immuni.2012.02.012
53. Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med (2007) 13:711-8. doi:10.1038/nm1585
54. Lenardo M, Chan KM, Hornung F, McFarland H, Siegel R, Wang J, et al. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol (1999) 17:221-53. doi:10.1146/annurev.immunol.17.1.221
55. Mingari MC, Gerosa F, Carra G, Accolla RS, Moretta A, Zubler RH, et al. Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells. Nature (1984) 312:641-3. doi:10.1038/312641a0
56. 17 and regulatory T cells in mediating and restraining inflammation. Cell (2010) 140:845-58. doi:10.1016/j.cell.2010.02.021
57. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell (2008) 133:775-87. doi:10.1016/j.cell.2008.05.009
58. Shevach EM. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity (2009) 30:636-45. doi:10.1016/j.immuni.2009.04.010
59. Kitas GD, Salmon M, Farr M, Gaston JS, Bacon PA. Deficient interleukin 2 production in rheumatoid arthritis: association with active disease and systemic complications. Clin Exp Immunol (1988) 73:242-9.
60. Avramescu C, Vere CC, Margaritescu C, Turculeanu A, Balasoiu M, Rogoz S. Cytokinic panel in rheumatoid arthritis and correlation with histological patterns of synovitis-active type of disease. Rom J Morphol Embryol (2005) 46: 87-92.
61. Kokkonen H, Söderström I, Rocklöv J, Hallmans G, Lejon K, Rantapää Dahlqvist S. Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum (2010) 62:383-91. doi:10.1002/art.27186
62. Liao W, Lin JX, Leonard WJ. Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity (2013) 38:13-25. doi:10.1016/j.immuni.2013.01.004
63. 4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity (2002) 17:167-78. doi:10.1016/S1074-7613(02)00367-9
64. Straub RH, Rauch L, Rauh L, Pongratz G. Sympathetic inhibition of IL-6, IFN-γ, and KC/CXCL1 and sympathetic stimulation of TGF-β in spleen of early arthritic mice. Brain Behav Immun (2011) 25:1708-15. doi:10.1016/j.bbi.2011.07.001
65. Loza MJ, Foster S, Peters SP, Penn RB. Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells. Blood (2006) 107:2052-60. doi:10.1182/blood-2005-08-3265
66. 2 cells are less responsive to negative feedback by receptors coupled to the AC/cAMP system compared to freshly isolated T cells. Br J Pharmacol (2003) 138:1441-50. doi:10.1038/sj.bjp.0705193
67. 4+ T cells exposed to norepinephrine. Brain Behav Immun (2000) 14:239-55. doi:10.1006/brbi.2000.0603
68. Hakonarson H, Herrick DJ, Serrano PG, Grunstein MM. Mechanism of cytokine-induced modulation of beta-adrenoceptor responsiveness in airway smooth muscle. J Clin Invest (1996) 97:2593-600. doi:10.1172/JCI118708
69. Chung MK, Gulick TS, Rotondo RE, Schreiner GF, Lange LG. Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction. Circ Res (1990) 67:753-63. doi:10.1161/01.RES.67.3.753
70. Whitehouse M. Oily adjuvants and autoimmunity: now time for reconsideration? Lupus (2012) 21:217-22. doi:10.1177/0961203311429818
71. 2 clones: implications for cytokine production and B cell help. J Immunol (1997) 158:4200-10.
72. Ramer-Quinn DS, Baker RA, Sanders VM. Activated T helper 1 and T helper 2 cells differentially express the beta-2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production. J Immunol (1997) 159:4857-67.
73. Heijnen CJ, Rouppe van der Voort C, Wulffraat N, van der Net J, Kuis W, Kavelaars A. Functional alpha 1-adrenergic receptors on leukocytes of patients with polyarticular juvenile rheumatoid arthritis. J Neuroimmunol (1996) 71:223-6. doi:10.1016/S0165-5728(96)00125-7
74. Huang JL, Zhang YL, Wang CC, Zhou JR, Ma Q, Wang X, et al. Enhanced phosphorylation of MAPKs by NE promotes TNF-a production by macrophage through a adrenergic receptor. Inflammation (2012) 35:527-34. doi:10.1007/s10753-011-9342-4
75. Donnelly LE, Tudhope SJ, Fenwick PS, Barnes PJ. Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophages. Eur Respir J (2010) 36:178-86. doi:10.1183/09031936.00158008
76. Tanaka S, Tsutsui M, Kishida T, Souma S, Kuroda J, Yoshida T. Salbutamol inhibits lipopolysaccharide-induced inflammatory responses in rat peritoneal macrophages. J Toxicol Sci (2010) 35:327-34. doi:10.2131/jts.35.327
77. Szelényi J, Kiss JP, Vizi ES. Differential involvement of sympathetic nervous system and immune system in the modulation of TNF-alpha production by alpha2-and beta-adrenoceptors in mice. J Neuroimmunol (2000) 103:34-40. doi:10.1016/S0165-5728(99)00234-9
78. Szelényi J, Kiss JP, Puskás E, Selmeczy Z, Szelényi M, Vizi ES. Opposite role of alpha2-and beta-adrenoceptors in the modulation of interleukin-10 production in endotoxaemic mice. Neuroreport (2000) 11:3565-8. doi:10.1097/00001756-200011090-00032
79. Suberville S, Bellocq A, Fouqueray B, Philippe C, Lantz O, Perez J, et al. Regulation of interleukin-10 production by beta-adrenergic agonists. Eur J Immunol (1996) 26:2601-5. doi:10.1002/eji.1830261110
80. Sanders VM, Straub RH. Norepinephrine, the beta-adrenergic receptor, and immunity. Brain Behav Immun (2002) 16:290-332. doi:10.1006/brbi.2001.0639
81. Fournier C. Where do T cells stand in rheumatoid arthritis? Joint Bone Spine (2005) 72:527-32. doi:10.1016/j.jbspin.2004.12.012
82. Wahle M, Krause A, Pierer M, Hantzschel H, Baerwald CG. Immunopathogenesis of rheumatic diseases in the context of neuroendocrine interactions. Ann N Y Acad Sci (2002) 966:355-64. doi:10.1111/j.1749-6632.2002.tb04235.x
83. 2 profile in patients with rheumatoid arthritis. Arthritis Res Ther (2006) 8:R138. doi:10.1186/ar2028
84. Roubenoff R, Roubenoff RA, Cannon JG, Kehayias JJ, Zhuang H, Dowson-Hughes B, et al. Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest (1994) 93:2379-86. doi:10.1172/JCI117244
85. Granado M, Martín AI, Villanúa MA, López-Calderón A. Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation. Am J Physiol Endocrinol Metab (2007) 292:E1656-65. doi:10.1152/ajpendo.00502.2006
86. Martín AI, Castillero E, Granado M, López-Menduiña M, Villanúa MA, López-Calderón A. Adipose tissue loss in adjuvant arthritis is associated with a decrease in lipogenesis, but not with an increase in lipolysis. J Endocrinol (2008) 197:111-9. doi:10.1677/JOE-07-0491
87. Summers GD, Deighton CM, Rennie MJ, Booth AH. Rheumatoid cachexia: a clinical perspective. Rheumatology (Oxford) (2008) 47:1124-31. doi:10.1093/rheumatology/ken146
88. Filippin LI, Teixeira VN, Viacava PR, Lora PS, Xavier LL, Xavier RM. Temporal development of muscle atrophy in murine model of arthritis is related to disease severity. J Cachexia Sarcopenia Muscle (2013) 4:231-8. doi:10.1007/s13539-013-0102-1
89. Roubenoff R, Freeman LM, Smith DE, Abad LW, Dinarello CA, Kehayias JJ. Adjuvant arthritis as a model of inflammatory cachexia. Arthritis Rheum (1997) 40:534-9. doi:10.1002/art.1780400320
90. Granado M, Martín AI, Priego T, López-Calderón A, Villanúa MA. Tumour necrosis factor blockade did not prevent the increase of muscular muscle RING finger-1 and muscle atrophy F-box in arthritic rats. J Endocrinol (2006) 191:319-26. doi:10.1677/joe.1.06931
91. Llovera M, García-Martínez C, Agell N, López-Soriano FJ, Argilés JM. TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles. Biochem Biophys Res Commun (1997) 230:238-41. doi:10.1006/bbrc.1996.5827
92. Holm BC, Lorentzen JC, Bucht A. Adjuvant oil induces waves of arthritogenic lymph node cells prior to arthritis onset. Clin Exp Immunol (2004) 137:59-64. doi:10.1111/j.1365-2249.2004.02498.x
93. Holmberg J, Tuncel J, Yamada H, Lu S, Olofsson P, Holmdah R. Pristane, a non-antigenic adjuvant, induces MHC class II-restricted, arthritogenic T cells in the rat. J Immunol (2006) 176:1172-9. doi:10.4049/jimmunol.176.2.1172
94. Shenoy SK, Drake MT, Nelson CD, Houtz DA, Xiao K, Madabushi S, et al. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J Biol Chem (2006) 281:1261-73. doi:10.1074/jbc.M506576200
95. Lombardi MS, Kavelaars A, Cobelens PM, Schmidt RE, Schedlowski M, Heijnen CJ. Adjuvant arthritis induces down-regulation of G protein-coupled receptor kinases in the immune system. J Immunol (2001) 166:1635-40. doi:10.4049/jimmunol.166.3.1635